Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tablet screening could help HIV patients get help for addiction and depression

NCT ID NCT03217058

Completed Knowledge-focused Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study tested a tablet-based screening system for substance use, depression, and anxiety in over 10,000 HIV-positive adults during routine clinic visits. Patients who screened positive were offered behavioral treatments like motivational interviewing and cognitive behavioral therapy. The goal was to see if this approach could increase screening and treatment rates, ultimately improving HIV care outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
computerized screening and behavioral interventions (motivational interviewing, cognitive behavioral therapy)
What this could lead to
If successful, this approach could make it easier for HIV clinics to identify and treat substance use, depression, and anxiety, potentially improving overall health outcomes for people living with HIV.
What could go wrong
This is an implementation study, not a test of a new drug or cure. Results may vary by clinic setting, and the screening tools may not work equally well for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder Depression depressive disorder HIV infectious disease substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANXIETY DEPRESSION HIV SUBSTANCE USE DISORDERS

Contacts and locations

Locations

  • Kaiser Permanente Division of Research

    Oakland, California, 94612, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.